APRICUS BIOSCIENCES, INC. Business Finance Contracts & Agreements

120 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Placement Agent Common Stock Purchase Warrant between Seelos Therapeutics, Inc. and H.C. Wainwright & Co., LLC (July 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (July 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Amendment No. 7 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Amendment No. 6 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Amendment No. 5 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers dated January 26, 2024
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (January 30, 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (December 1, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Pre-Funded Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (December 1, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2023
Underwriting Agreement between Seelos Therapeutics, Inc. and Titan Partners Group LLC as Representative of the Underwriters
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 4 to Convertible Promissory Note and Letter Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers (September 21, 2023)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (Dated September 25, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 1 to Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers
Modification Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Seelos Therapeutics, Inc. Common Stock Purchase Warrant Agreement (May 19, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 3 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (March 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Pre-Funded Common Stock Purchase Warrant between Seelos Therapeutics, Inc. and Holder (March 14, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 2 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Common Stock Purchase Agreement between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited (November 24, 2021)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Security Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (November 23, 2021)
Security Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Seelos Therapeutics, Inc. $22,000,000 Convertible Promissory Note to Lind Global Asset Management V, LLC (Due November 23, 2024)
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement between Seelos Therapeutics, Inc. and Guggenheim Securities, LLC dated May 20, 2021
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement between Seelos Therapeutics, Inc. and BTIG, LLC dated January 25, 2021
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Security Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC dated December 11, 2020
Security Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Seelos Therapeutics, Inc. Convertible Promissory Note Due December 11, 2022 with Lind Global Asset Management II, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2020
Underwriting Agreement between Seelos Therapeutics, Inc. and The Benchmark Company, LLC (March 11, 2020)
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Underwriting Agreement between Seelos Therapeutics, Inc. and The Benchmark Company, LLC (February 10, 2020)
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Underwriting Agreement for Public Offering of Common Stock by Seelos Therapeutics, Inc. and The Benchmark Company, LLC
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Stock Purchase Agreement between Seelos Therapeutics, Inc. and Phoenixus AG (January 2, 2020)
Stock Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers dated March 10, 2023
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 5 to Asset Purchase Agreement between Seelos Corporation and Phoenixus AG (April 8, 2022)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (November 23, 2021)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Amendment No. 4 to Asset Purchase Agreement between Phoenixus AG and Seelos Corporation (February 15, 2021)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (December 11, 2020)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers dated September 4, 2020
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Amendment No. 2 to Asset Purchase Agreement between Seelos Therapeutics, Inc. and Phoenixus AG (f/k/a Vyera Pharmaceuticals AG and Turing Pharmaceuticals AG)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2019
Amendment No. 3 to Asset Purchase Agreement between Seelos Therapeutics, Inc. and Phoenixus AG (October 15, 2019)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NV
2019